Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00496613 · ClinicalTrials.gov registry record
Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 200
- Enrollment target
NCT00496613: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00496613 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00496613 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about how chemotherapy affects an individual's thinking abilities (cognition). Some research has shown that chemotherapy can cause changes in cognition in breast cancer survivors. However, it is not clear why this change occurs. In this study, the investigators will look to see if damage to DNA is related to these changes in cognition. Specifically, the investigators want to see 1) if women who have been treated with chemotherapy have more DNA damage than healthy women; and 2) if DNA damage is related to cognitive problems in breast cancer survivors and healthy women.
Interventions
- BEHAVIORAL Mini-Mental State Exam and Blood draw
- BEHAVIORAL Mini-Mental State Exam and Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2007-06 |
| Est. Completion | 2022-04-18 |
What the finished NCT00496613 record still lists
NCT00496613 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Mini-Mental State Exam and Blood draw is the first listed.
NCT00496613 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00496613 about?
NCT00496613 is a clinical study titled "Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors". The purpose of this study is to learn more about how chemotherapy affects an individual's thinking abilities (cognition). Some research has shown that chemotherapy can cause changes in cognition in breast cancer survivors. However, it is not clear why this change occurs. In this study, the investiga...
What is the current status of trial NCT00496613?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2007-06. Estimated completion is 2022-04-18.
What interventions are being tested in trial NCT00496613?
The interventions under investigation include: Mini-Mental State Exam and Blood draw (BEHAVIORAL), Mini-Mental State Exam and Blood Draw (BEHAVIORAL).
Who is sponsoring clinical trial NCT00496613?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia